Organovo Achieves 3D Tissue Model for Crohn's Disease

Stock Information for Organovo Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Organovo Holdings Inc.

Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn's Disease Drug Candidates
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Organovo Announces Postponement of Annual Meeting of Stockholders
UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Organovo Welcomes New Sr. Vice President of Strategy and Business Development
Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.